Kite Lake Capital Management (UK)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-350,773	Closed	-$39M	–	11
2020 Q3	$39M	Buy	350,773 +49,000	+16%	+$5.26M	38.98%	1
2020 Q2	$30.8M	Buy	301,773 +54,000	+22%	+$5.78M	47.96%	1
2020 Q1	$26.7M	Buy	247,773 +40,391	+19%	+$4.64M	42.68%	1
2019 Q4	$24.1M	Buy	+207,382	New	+$24M	76.46%	1
2019 Q1	–	Sell	-195,240	Closed	-$14.8M	–	17
2018 Q4	$14.8M	Buy	+195,240	New	+$14.4M	4.74%	10

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Kite Lake Capital Management (UK)'s CBPO Position: Q4 2020 in Review

Kite Lake Capital Management (UK) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 350,773 shares — an estimated $39M sold.

Kite Lake Capital Management (UK) first reported a position in CBPO in Q4 2018 and held it in 5 quarters. The position peaked at $39M in Q3 2020. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Kite Lake Capital Management (UK) reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Kite Lake Capital Management (UK) sold 350,773 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $39M.
Kite Lake Capital Management (UK) first reported a position in China Biologic Products Holdings, Inc. in Q4 2018 and held it in 5 quarters.
Kite Lake Capital Management (UK)'s China Biologic Products Holdings, Inc. position peaked at $39M in Q3 2020.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q4 2020, filed 16 Feb 2021.